Perrigo

About:

Perrigo is a pharmaceutical and consumer goods company that produces a variety of over-the-counter and generic prescription pharmaceuticals.

Website: http://www.perrigo.com

Twitter/X: PerrigoCareers

Top Investors: Starboard Value, BofA Securities, JP Morgan Chase, Wells Fargo Securities, Hao Capital

Description:

Perrigo Company plc is a leading global healthcare supplier that develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. It has a presence in multiple countries and serves customers around the world.

Total Funding Amount:

$4.58B

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

1887-01-01

Contact Email:

socialmedia(AT)perrigo.com

Founders:

Charles Perrigo, Luther Perrigo

Number of Employees:

10001+

Last Funding Date:

2024-09-12

IPO Status:

Public

© 2025 bioDAO.ai